| PERIOD ENDING | 28-Mar-09 | 31-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 2,255,100 | 2,646,300 | 2,588,100 | 2,709,600 | | Cost of Revenue | 1,368,200 | 1,579,300 | 1,555,400 | 1,621,500 | | | Gross Profit | 886,900 | 1,067,000 | 1,032,700 | 1,088,100 | | | Operating Expenses | | Research Development | 58,200 | 60,900 | 61,800 | 64,400 | | Selling General and Administrative | 625,000 | 663,100 | 669,200 | 698,900 | | Non Recurring | 13,600 | 20,500 | 15,400 | (5,400) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 190,100 | 322,500 | 286,300 | 330,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,300 | 3,200 | 12,000 | 13,900 | | Earnings Before Interest And Taxes | 197,400 | 329,100 | 298,300 | 344,100 | | Interest Expense | 30,200 | 28,800 | 34,100 | 36,600 | | Income Before Tax | 167,200 | 300,300 | 264,200 | 307,500 | | Income Tax Expense | 18,300 | 9,600 | 45,900 | 61,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 148,900 | 290,700 | 218,300 | 246,300 | | | Non-recurring Events | | Discontinued Operations |
-
| (500) | 3,200 | 3,200 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 148,900 | 290,200 | 221,500 | 249,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $148,900 | $290,200 | $221,500 | $249,500 |
|
0.45% Nasdaq 
0.20%
Income Statement
